FDA Drug Application (009282) for CEDILANID-D by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number009282
Product Number002
FormINJECTABLE;INJECTION
Dosage0.2MG/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCEDILANID-D
Active IngredientDESLANOSIDE



Back to FDA Applications sponsored by NOVARTIS